Richard Pietras to Receptors, Estrogen
This is a "connection" page, showing publications Richard Pietras has written about Receptors, Estrogen.
Connection Strength
3.817
-
Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol. 2018 05 05; 466:51-72.
Score: 0.562
-
Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 2011 Aug; 76(9):910-20.
Score: 0.357
-
Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res. 2007 Aug 15; 13(16):4672-6.
Score: 0.276
-
Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res Treat. 2008 Apr; 108(3):351-61.
Score: 0.273
-
Biologic basis of sequential and combination therapies for hormone-responsive breast cancer. Oncologist. 2006 Jul-Aug; 11(7):704-17.
Score: 0.255
-
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol. 2006 Feb 26; 246(1-2):91-100.
Score: 0.247
-
Estrogen receptors and cell signaling. Science. 2005 Oct 07; 310(5745):51-3; author reply 51-3.
Score: 0.243
-
Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature. Breast J. 2003 Sep-Oct; 9(5):361-73.
Score: 0.210
-
Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocrine. 2001 Nov; 16(2):73-81.
Score: 0.185
-
Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 2001 Sep 06; 20(39):5420-30.
Score: 0.183
-
Cell membrane estrogen receptors resurface. Nat Med. 1999 Dec; 5(12):1330.
Score: 0.162
-
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy. J Steroid Biochem Mol Biol. 2019 10; 193:105415.
Score: 0.157
-
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene. 1995 Jun 15; 10(12):2435-46.
Score: 0.119
-
Estrogen-signaling pathways in lung cancer. Adv Exp Med Biol. 2008; 617:281-9.
Score: 0.071
-
Subcellular distribution of oestrogen receptors. Nature. 1985 Sep 5-11; 317(6032):88-9.
Score: 0.060
-
New approaches to reverse resistance to hormonal therapy in human breast cancer. Drug Resist Updat. 2005 Aug; 8(4):219-33.
Score: 0.060
-
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids. 2005 May-Jun; 70(5-7):372-81.
Score: 0.058
-
Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc Natl Acad Sci U S A. 2005 Feb 15; 102(7):2632-6.
Score: 0.058
-
Specific internalization of estrogen and binding to nuclear matrix in isolated uterine cells. Biochem Biophys Res Commun. 1984 Aug 30; 123(1):84-91.
Score: 0.056
-
Immunologic inhibition of estrogen binding and action in preputial-gland cells and their subcellular fractions. J Steroid Biochem. 1981 Aug; 14(8):679-91.
Score: 0.045
-
Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J. 1980 Dec 01; 191(3):743-60.
Score: 0.043
-
Estrogen receptors in uterine plasma membrane. J Steroid Biochem. 1979 Oct; 11(4):1471-83.
Score: 0.040
-
Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17beta. J Cell Physiol. 1979 Jan; 98(1):145-59.
Score: 0.038
-
Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977 Jan 06; 265(5589):69-72.
Score: 0.033
-
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):270-8.
Score: 0.025